Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-04-26 | New | $10,044,498 | $10,044,498 | Equity Only | 06b | SEC link |
| 2020-06-11 | New | $10,000,000 | $10,000,000 | Equity Only | 06b | SEC link |
| 2019-06-17 | Amended | $7,735,500 | $3,858,500 | Debt Only | 06b | SEC link |
| 2018-10-25 | New | $3,877,000 | $3,877,000 | Debt Only | 06b | SEC link |
| 2017-02-09 | New | $175,000 | $175,000 | Debt Only | 06b | SEC link |
| Name | Role |
|---|---|
| Steven Altschuler | Director |
| Steven Altschuler, Md | Director |
| Ben Askew | Director |
| Joshua Barer | Director |
| Josh Barer | Director |
| Robert Dempsey | Executive |
| Chris Garabedian | Director |
| Jordan Green | Director |
| Niranjan Pandey | Executive |
| Wendy Perrow | Director, Executive |
| Aleksander Popel | Executive |
| Aleksander S. Popel, Ph D | Director |
| Amir Shojaei | Executive |
| Kevin Slawin, Md | Director, Executive |
| Sapna Srivastava | Director |
| Jill Tierney | Executive |